Built for eczema-prone skin. Backed by science. Now 10% Off Your First Order.

Preview text: Developed by scientists studying chronic skin inflammation.

Tuesday, Jun 2, 2026 at 5:04 AM EasternActiveCampaign

Integrative Dermatology SymposiumBuilt for eczema-prone skin. Backed by science. Now 10% Off Your First Order.

Image not available

No image available for this email.

Subject: Built for eczema-prone skin. Backed by science. Now 10% Off Your First Order.
Preview text: Developed by scientists studying chronic skin inflammation.
From: info@learnskin.com
Brand: Integrative Dermatology Symposium
ESP: ActiveCampaign
Sent: Tue Jun 2, 2026, 5:04 AM ET
Size: 33 KB
Images: 11
Links: 14, 2 of them buttons
Subject length: 78 characters

Against Integrative Dermatology Symposium's usual

Sent in its busiest hour, 5 AM, which holds 77% of its emails. The subject is 78 characters; its average is 59.

Email headers

What the brand's servers put on this email. Our receiving servers, the address we subscribed with and unsubscribe links are left out.

From: LearnSkin <[email protected]>
Subject: Built for eczema-prone skin. Backed by science. Now 10% Off Your First Order.
Date: Tue, 2 Jun 2026 09:04:26 +0000 (GMT)
Message-ID domain: cell-4-9768d8447-5zzl4
Return-Path domain: em-727738.learnskin.com
DKIM signature: d=learnskin.com s=acdkim1; d=acems3.com s=acdkim1
List-Unsubscribe: Present, one-click
Mailer: ActiveCampaign Mailer
Feedback-ID sender: activecampaign

Other sending headers (names only): X-KumoRef, X-DKIM-Options, X-Virtual-Mta, X-250ok-CID, X-Sending-Engine, X-Report-Abuse, X-lid, X-mid

	Jun 10, 2026 3:02 PM	From Gut to Skin: How Early-Life Microbiome Development Shapes the Atopic March
	Jun 5, 2026 5:03 AM	One Week in Palm Springs. Two Ways to Rethink Skin Health
	Jun 3, 2026 5:05 AM	New Insights Into Type 2 Inflammation Across Dermatology
	Jun 2, 2026 5:04 AM	Built for eczema-prone skin. Backed by science. Now 10% Off Your First Order. (this email)
	Jun 1, 2026 5:04 AM	What Connects These Skin Conditions?
	May 30, 2026 6:04 AM	The Type 2 Interface: Unifying AD, CSU, and PN Pathophysiology and Dispelling Common Misconceptions
	May 29, 2026 5:05 AM	What Patients Are Asking About Eczema and Itch